Navigation Links
Torigen Appoints Veterinary Oncologist, Dr. Chelsea Greenberg, as Vice President of Clinical Affairs

Continuing its momentum to become the industry leader in veterinary biologics, Torigen Pharmaceuticals Inc., today announced that the company has added Dr. Chelsea Greenberg, MS, DVM, DACVIM(O), a veterinary oncologist from Salt Lake City, Utah as its Vice President of Clinical Affairs.

Dr. Greenberg has been a veterinary oncologist for more than 15 years and a veterinary oncology teleconsultant for over 12 years. She joins Torigen as the Vice President of Clinical Affairs, working alongside veterinary hospitals and assisting with clinical trials to advance new cancer therapeutics into the market.

Prior to joining Torigen, Dr. Greenberg was most recently medical director and clinical oncologist for BluePearl Salt Lake City and BluePearl Regional Vice President of Medicine for multiple specialty/ER hospitals in Arizona, California, Nevada, Utah, and Washington state.

At Purdue University’s Comparative Oncology Program, she was a clinical assistant professor teaching students, interns, and residents while also managing clinical trials. She completed her oncology residency at Purdue and her DVM at the University of Missouri, Columbia.

Torigen, a commercial-stage animal health biologics company is currently preparing for its next equity round of financing in order to facilitate the in-licensing of additional companion animal cancer therapeutics and expand existing business units.

“I am so excited for Dr. Chelsea Greenberg to be joining our team at Torigen,” said Ashley Kalinauskas, CEO and Co-Founder of Torigen. “She has incredible experience at both the academic and clinical levels and will help us achieve our goals to establish Torigen as a leader in the veterinary oncology market.”

With approximately 350 practicing veterinary oncologists in the U.S., Torigen now has two prominent oncologists on staff.

“The Torigen team is such a motivated and compassionate group dedicated to improving cancer care for pets,” said Dr. Greenberg. “I am thrilled to have this opportunity.”

About Torigen’s Autologous Cancer Vaccine:
Torigen produces a personalized autologous prescription product for dogs, cats, and horses that uses the animal’s own tumor cells to create an immunotherapy from a surgically resected portion of tumor that can be used alone or in combination with chemotherapy and radiation. Torigen’s autologous prescription product is an experimental product regulated by the USDA Center of Veterinary Biologics under 9 CFR 103.3.

Torigen’s autologous prescription product is an active immunotherapy consisting of cells harvested from the patient’s own tumor. This whole cell tumor vaccine is generated by a patented method to preserve cellular material and tumor associated antigens, and then mixed them with immune stimulating adjuvants. The objective is to increase activation of tumor-specific T-cells resulting in an enhanced ability of the pet’s immune system to destroy cancer cells, stop or slow the growth of cancer cells, or delay cancer metastasis.

About Torigen Pharmaceuticals Inc.:
Torigen is a spin-out from the University of Notre Dame and backed by Emerald Development Partners, The University of Connecticut, SoGal Ventures, The Fund, Gaingels, Connecticut Innovations, Aimers Venture Partners, and other prominent investors.

With over 50% of all dogs over the age of 10 dying from cancer, Torigen is dedicated to providing affordable and effective cancer care solutions for all companion animals. Torigen recognizes the instrumental role pets play in our families, and is determined to extend the lives of companion animals despite a cancer diagnosis.

For more information about Torigen, please visit

Read the full story at

Source: PRWeb
Copyright©2021 Vocus, Inc.
All rights reserved

Related medicine news :

1. Torigen Wins Big at Yale Innovation Summit and Animal Health Innovation Showcase
2. Codoxo Appoints Rajesh Razdan as Vice President of Products
3. ClearGage Strengthens Management Team And Appoints Strategic Board Advisors
4. Mercy College Appoints Dr. Kathleen Golisz Interim Dean for the School of Health and Natural Sciences
5. Evergreen Research Appoints New President, Natasha Bond
6. Pace University Appoints New Dean for its College of Health Professions
7. Key Transitions Appoints Dr. Kim Chronister as Their Teen Treatment Program Clinical Director
8. Relatient Appoints David Klasnick as Chief Operating Officer
9. Morehouse School of Medicine Appoints Dr. Joseph A. Tyndall As Dean And Executive Vice President For Health Affairs
10. SchoolCare Appoints Kevin McDonald as Chief Growth Officer
11. Memorial Healthcare System Appoints Marc L. Napp, MD, MS, FACS, as SVP and Chief Medical Officer
Post Your Comments:
(Date:3/30/2021)... , ... March 29, 2021 , ... ... the 21st Century , A Virtual Workshop Presented by WCG FDAnews and Cerulean ... 4:30 pm EDT, , Are one’s SOPs written for the ...
(Date:3/30/2021)... ... March 29, 2021 , ... According to data released ... reproductive age (13-44) in need of publicly funded contraception live in counties impacted by ... Colorado’s 64 counties have lost some of their Title X resources. , The ...
(Date:3/30/2021)... ... March 29, 2021 , ... Health Literacy Innovations (HLI), a ... confusion due to low health literacy today announces a new partnership with the ... work with ACAP’s member Safety Net Health Plans, those that provide comprehensive health ...
(Date:3/30/2021)... ... ... Dr. Colin Campbell is proud to announce the 1 year anniversary in their new state ... internal medicine and is a primary care specialist who has been practicing for 23 years. ... keep South Jersey healthy one patient at a time. , “Over the past year, Dr. ...
(Date:3/30/2021)... ... March 30, 2021 , ... The COVID-19 ... and survivors; their families; and their caregivers. Crossroads4Hope is addressing the needs of ... emotional support system, MyGo2Support, which meets needs of people impacted by cancer, no ...
Breaking Medicine News(10 mins):
(Date:3/30/2021)... ... March 29, 2021 , ... The University of Texas Health Science Center ... San Antonio Multispecialty and Research Hospital, a destination center for research and treatment of ... In a nod to the COVID-19 pandemic, the ceremony was held virtually. , William ...
(Date:3/30/2021)... ... March 29, 2021 , ... Iora Health ... primary care, has partnered with Devoted Health , one of the fastest-growing ... across Maricopa County and provides seniors with the highest-quality care and experience possible, ...
(Date:3/30/2021)... CITY (PRWEB) , ... March 29, 2021 , ... ... has joined the Vaccine Credential Initiative (VCI), a group bringing together leading health ... record of vaccination status, based on open, interoperable standards. By joining the VCI ...
Breaking Medicine Technology: